Unlock stock picks and a broker-level newsfeed that powers Wall Street.
52.91
-1.70
(-3.12%)
At close: April 7 at 5:03:36 PM GMT+1
Research Analysis
Earnings Estimate
Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
---|---|---|---|---|
No. of Analysts | -- | -- | -- | -- |
Avg. Estimate | 0 | 0 | 0 | 0 |
Low Estimate | 0 | 0 | 0 | 0 |
High Estimate | 0 | 0 | 0 | 0 |
Year Ago EPS | -- | -- | -- | -- |
Revenue Estimate
Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
---|---|---|---|---|
No. of Analysts | 5 | 5 | 6 | 6 |
Avg. Estimate | 311.18M | 316.75M | 1.27B | 1.33B |
Low Estimate | 305.51M | 309.58M | 1.24B | 1.27B |
High Estimate | 316.59M | 325.34M | 1.3B | 1.39B |
Year Ago Sales | 298.36M | 312.94M | 1.24B | 1.27B |
Sales Growth (year/est) | 4.30% | 1.22% | 2.45% | 4.72% |
EPS Trend
Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
---|---|---|---|---|
Current Estimate | 0 | 0 | 0 | 0 |
7 Days Ago | 0 | 0 | 0 | 0 |
30 Days Ago | 0 | 0 | 0 | 0 |
60 Days Ago | 0 | 0 | 0 | 0 |
90 Days Ago | 0 | 0 | 0 | 0 |
EPS Revisions
Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
---|---|---|---|---|
Up Last 7 Days | -- | -- | -- | -- |
Up Last 30 Days | -- | -- | -- | -- |
Down Last 7 Days | -- | -- | -- | -- |
Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
Current Qtr. | Next Qtr. | Current Year | Next Year | |
---|---|---|---|---|
0U95.L | -- | -- | -- | -- |
S&P 500 | 6.56% | 6.52% | 9.72% | 14.29% |
Upgrades & Downgrades
Reiterates | RBC Capital: Outperform to Outperform | 2/18/2025 |
Maintains | Keefe, Bruyette & Woods: Outperform to Outperform | 2/18/2025 |
Maintains | Keefe, Bruyette & Woods: Outperform to Outperform | 1/8/2025 |
Downgrade | Barclays: Overweight to Equal-Weight | 1/6/2025 |
Maintains | Keefe, Bruyette & Woods: Outperform to Outperform | 12/10/2024 |
Maintains | JP Morgan: Neutral to Neutral | 12/9/2024 |